Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Progress of circRNA/lncRNA-miRNA-mRNA axis in atrial fibrillation. | PeerJ | 2023 | 38144204 | PubTator, text mining | PubMed |
| 3D printed scaffolds based on hyaluronic acid bioinks for tissue engineering: a review. | Biomater Res | 2023 | 38142273 | PubTator, text mining | PubMed |
| Hyaluronic Acid Nanogels: A Promising Platform for Therapeutic and Theranostic Applications. | Pharmaceutics | 2023 | 38140012 | PubTator, text mining | PubMed |
| The Nexus of Inflammation-Induced Epithelial-Mesenchymal Transition and Lung Cancer Progression: A Roadmap to Pentacyclic Triterpenoid-Based Therapies. | Int J Mol Sci | 2023 | 38139154 | PubTator, text mining | PubMed |
| Association between glycolysis markers and prognosis of liver cancer: a systematic review and meta-analysis. | World J Surg Oncol | 2023 | 38114977 | PubTator, text mining | PubMed |
| Favorable outcome of a histiocytic sarcoma patient treated with immune checkpoint inhibitor: a case report. | Ann Med Surg (Lond) | 2023 | 38098600 | PubTator, text mining | PubMed |
| Comprehensive Profiling and Therapeutic Insights into Differentially Expressed Genes in Hepatocellular Carcinoma. | Cancers (Basel) | 2023 | 38067357 | PubTator, text mining | PubMed |
| Microglia Polarization and Antiglioma Effects Fostered by Dual Cell Membrane-Coated Doxorubicin-Loaded Hexagonal Boron Nitride Nanoflakes. | ACS Appl Mater Interfaces | 2023 | 38051559 | PubTator, text mining | PubMed |
| An Overview of Supramolecular Platforms Boosting Drug Delivery. | Bioinorg Chem Appl | 2023 | 38028018 | PubTator, text mining | PubMed |
| Targeting B4GALT7 suppresses the proliferation, migration and invasion of hepatocellular carcinoma through the Cdc2/CyclinB1 and miR-338-3p/MMP2 pathway. | PeerJ | 2023 | 38025683 | PubTator, text mining | PubMed |
| Treatment of Scleroderma-Related Microstomia Using Hyaluronic Acid: An Interventional Study. | Life (Basel) | 2023 | 38004316 | PubTator, text mining | PubMed |
| Exome Sequencing Reveals Novel Germline Variants in Breast Cancer Patients in the Southernmost Region of Thailand. | J Pers Med | 2023 | 38003901 | PubTator, text mining | PubMed |
| Biopolymers for Tissue Engineering: Crosslinking, Printing Techniques, and Applications. | Gels | 2023 | 37998980 | PubTator, text mining | PubMed |
| Big data analysis identified a telomere-related signature predicting the prognosis and drug sensitivity in lung adenocarcinoma. | Medicine (Baltimore) | 2023 | 37986388 | PubTator, text mining | PubMed |
| Advancing personalized medicine in brain cancer: exploring the role of mRNA vaccines. | J Transl Med | 2023 | 37978542 | PubTator, text mining | PubMed |
| A comprehensive pan-cancer analysis identifies a novel glycolysis score and its hub genes as prognostic and immunological biomarkers. | Transl Cancer Res | 2023 | 37969385 | PubTator, text mining | PubMed |
| The Hyaluronan/CD44 Axis: A Double-Edged Sword in Cancer. | Int J Mol Sci | 2023 | 37958796 | PubTator, text mining | PubMed |
| The Role of Macrophages in Sarcoma Tumor Microenvironment and Treatment. | Cancers (Basel) | 2023 | 37958467 | PubTator, text mining | PubMed |
| Network based approach to identify interactions between Type 2 diabetes and cancer comorbidities. | Life Sci | 2023 | 37949208 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance. | J Transl Med | 2023 | 37936202 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=9